This webinar is for healthcare providers that may be seeing or treating patients, or have colleagues treating patients with Huntington's disease. Learn more about HD and current HSG clinical trials enrolling participants for HD treatments in North America.
The first 1-hour webinar will be held on Tuesday, March 30, 2021 at 5:30 pm EST / 2:30 pm PST.
Attendance is free through Zoom. We just ask that participants sign up in advance using the registration link below.
REGISTER FOR WEBINAR --> https://us02web.zoom.us/webinar/register/WN_G2_GsYaYSSmnNzGw-33DcQ
The HSG is a 501(c)(3) non-for-profit whose mission is to educate and raise awareness about Huntington disease, a rare neurodegenerative disorder affecting approximately 40,000 people in the United States. Another 200,000 people in the U.S. are estimated to be at risk for developing symptoms. The HSG also advises and conducts clinical research focused exclusively on HD.
Our hope is that by providing these educational webinars, we can enhance HD specific care, awareness, and HD community participation in clinical research. We are striving to inform HCPs about current clinical trials focused on potential treatments that make a difference for HD patients and families struggling with this devastating disease.